Investigation of the neurochemical, molecular and behavioural properties of the putative lithium-mimetic, ebselen

<p>Lithium is the first choice drug for the treatment of bipolar disorder and it is also used as supplementary therapy for treatment-resistant depression. A leading candidate target of lithium is inositol monophosphatase (IMPase) which is critically involved in signalling via the phosphoinosit...